They showed that the p53 protein, which is frequently mutated or downregulated in prostate cancer, promotes the expression of RBM25, an RNA-binding protein that interacts with AMOTL1 pre-mRNA and promotes circAMOTL1 formation. This evidence concerns the gene AMOTL1 and prostate carcinoma.